Management Team
THOMAS E. GARDNER–PRESIDENT & CHIEF EXECUTIVE OFFICER
Thomas E. Gardner is the president and chief executive officer of EuroMed Inc. Prior to joining EuroMed, Gardner was CEO of a number of public and private companies including NUCRYST Pharmaceuticals (sold to Smith & Nephew), Songbird Hearing (sold controlling interest to a major consumer packaged goods company), Datamonitor (IPO on London Stock Exchange), Base Ten Systems (assets purchased by Smiths Aerospace and ABB Group), and Access Health (now McKesson Health Solutions). He also held marketing and general management positions at Procter & Gamble, Johnson & Johnson, Simon & Schuster and IMS Health.
Gardner received a B.A. in Economics and Mathematics from the University of St. Thomas in Minnesota and has been a guest lecturer at Northwestern University’s Kellogg Graduate School of Management. He is a resident of Princeton, N.J.
–
STEPHEN POWELL–VICE PRESIDENT OF OPERATIONS
Steve joins us as our VP of Operations with over 23 years of diverse and successful production and operations experience, including 19 years working directly with Medical Devices. He graduated from Lehigh University in 1984 with a BS in Materials Engineering. Steve has held a variety of positions throughout his career that have progressed from Production Supervision and varied Engineering assignments to senior level Manufacturing and Operations positions. For the 6 years prior to joining Euromed, Steve held the position VP of Manufacturing and Board of Directors member for Bio-Chem Fluidics based in Boonton, NJ and Cambridge, UK.
Steve has extensive cellular manufacturing, Lean, JIT, and manufacturing leadership experience. Additionally, Steve brings to Euromed extensive product launch, organizational development, and ERP implementation experience that has been realized at companies ranging in size from small privately held “re-starts” to 3 billion dollar organizations like Stryker where he spent 10 years earlier in his career.
–
SIMON S. CHAN, JD–DIRECTOR OF INTERNATIONAL DEVELOPMENT
Simon S. Chan, JD serves as Director of International Development. Prior to joining Euromed, Inc., Mr. Chan served as Consultant and Director of Business Development for Pulse Metric, manufacturer of non-invasive hemodynamic devices for cardiovascular disease, hypertension and diabetes. As a consultant, Mr. Chan instituted $5 million venture capital funding for a New Jersey medical device company. As a Director of Business Development, he established over $35 million of business development, clinical development and product management during his tenure.
Mr. Chan brings expertise to Euromed for establishing international contracts, regulatory know-how and distribution networks to expand SureSkin brand. Within a short period, Mr. Chan has established potential partnerships with leading Asian, South American, and Middle Eastern companies.
Mr. Chan holds a Bachelor in Biochemistry and Cellular Biology from University of California, San Diego. Mr. Chan received a dean’s scholarship for graduate study in Thailand for international business. Mr. Chan also holds a Juris Doctor degree from Western State College of Law.
–
RAVI RAMJIT, PH.D–MANAGER, RESEARCH AND DEVELOPMENT
Dr. Ravi Ramjit serves as Head of Research and Development at Euromed Incorporated—joining in 2007. Prior to taking this position, he was a Product Development Engineer. Within a short period, Ramjit was promoted to Manager of R&D where he focused on bringing innovation to, and expediting product development. His knowledge of product development for medical devices via Design Control, regulatory requirements (FDA, CE), risk assessment, has allowed him to spearhead projects ranging from Silver Hydrocolloid OTC Bandages to Foam Plus (patent pending) wound dressings as well as product development concepts relating to Negative Pressure Wound Therapy (NPWT) and Botanical Wound Healing. Ramjit aims to develop a solid research and development foundation within Euromed, whereby innovative product development will lead to next generation wound healing technologies. He leads a team of six engineers from various disciplines including mechanical, biochemical, and electrical engineering.
Ramjit holds a PhD in Chemical Engineering from Polytechnic University, Engineering Institute of New York University where he also earned an MS in Biomedical Engineering and BS in Chemistry/Biomedical Science. His dissertation involved working with “nanomotors” responsible for transcribing DNA and eventually producing every protein found in the body. During his post-doctoral training, he worked in the distinguished laboratory of Dr. Stephen Arnold in the Microparticle Photophysics Laboratory for BioPhotonics (MP3L). There he was part of an interdisciplinary team whose goal was to detect potent viruses using a custom-built, state-of-the-art optics based biosensor. Ramjit has authored publications in various scientific journals including Nano Letters and Faraday Discussions.
